New Generic Abortion Pill Approved: What It Means for Investors
In a significant regulatory development, the FDA has granted approval for yet another generic version of the abortion pill mifepristone. This decision, while procedural in nature, has ignited a wave of discontent among conservative factions and anti-abortion advocates, particularly those aligned with the Trump administration. The implications of this approval extend beyond social issues, potentially … Read more